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Abstract
Traumatic brain injury (TBI) is one of the major causes of death and disability in pediatrics, and 
results in a complex cascade of events including the disruption of the blood-brain barrier (BBB). 
A controlled-cortical impact on post-natal 17 day-old rats induced BBB disruption by IgG 
extravasation from 1 to 3 days after injury and returned to normal at day 7. In parallel, we 
characterized the expression of three caveolin isoforms, cav-1, cav-2 and cav-3. While cav-1 and 
cav-2 are expressed on endothelial cells, both cav-1 and cav-3 were found to be present on 
reactive astrocytes, in vivo and in vitro. Following TBI, cav-1 expression was increased in blood 
vessels at 1 and 7 days in the perilesional cortex. An increase of vascular cav-2 expression was 
observed 7 days after TBI. In contrast, astrocytic cav-3 expression decreased 3 and 7 days after 
TBI. Activation of eNOS (via its phosphorylation) was detected 1 day after TBI and phospho-
eNOS was detected both in association with blood vessels and with astrocytes. The molecular 
changes involving caveolins occurring in endothelial cells following juvenile-TBI might 
participate, independently of eNOS activation, to a mechanism of BBB repair while, they might 
subserve other undefined roles in astrocytes.
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INTRODUCTION
Traumatic brain injury (TBI) affects about 1.7 million persons annually and accounts for 
about 30.5% of all injury-related deaths in the United States. Children and adolescents aged 
between 0 and 14 years represent a vulnerable population with half a million TBI-related 
emergency department visits annually (Faul et al., 2010). As such, juvenile TBI (jTBI) is a 
leading cause of death and disability in children and adolescents in the United States 
(Schneier et al., 2006). TBI is defined as brain damage that results from an external 
mechanical force (e.g. rapid acceleration or deceleration), blast waves, penetration by a 
projectile, or direct impact, and it is often accompanied by a post-injury concussion or 
similar forms of altered consciousness. In connection with the primary injury, jTBI is 
associated with secondary events, which include hemorrhage, disruption of the blood-brain 
barrier (BBB), and vasogenic edema (Pop and Badaut, 2011). TBI in the juvenile population 
has been associated with greater risks of cerebral hemodynamic dysfunction, hypoxic-
ischemic injury, and diffuse cerebral edema compared to adults (Giza et al., 2007). In an 
experimental model of jTBI, we have previously shown an increase in brain water content 
during the first week post-injury using T2-weighted MRI (Fukuda et al., 2012). TBI-induced 
vascular changes have been shown to alter endothelial phenotypes both acutely and 
chronically after injury (Pop and Badaut, 2011, Pop et al., 2013). Interestingly, recent 
studies have associated caveolin-1 (cav-1) with BBB dysfunctions in several brain injury 
models (Jasmin et al., 2007, Nag et al., 2007, Nag et al., 2009, Gu et al., 2011). However, 
controversial reports have been published on the role of cav-1 in acute BBB dysfunctions 
after brain injuries: a beneficial role of increased cav-1 by inhibition of NO synthesis (Gu et 
al., 2011) or a deleterious role with harmful effects on the BBB (Nag et al., 2007, Nag et al., 
2009, Chang et al., 2011).
Caveolins are structural proteins involved in the formation of caveolae, which are known to 
be involved in endocytosis, transcytosis, and exocytosis in endothelial cells (Predescu et al., 
2007). Three caveolin isoforms are known to be expressed in the mammalian brain 
(Cameron et al., 1997, Virgintino et al., 2002). Cav-1 and caveolin-2 (cav-2) have been 
mostly found in brain endothelial cells (Virgintino et al., 2002) although cav-1 has also been 
observed in some neurons and astrocytes (Cameron et al., 1997, Virgintino et al., 2002). 
Brain caveolin-3 (cav-3) has been predominantly described in astrocytes (Virgintino et al., 
2002, Shin et al., 2005). Besides facilitating the caveolae sequestration of several receptors, 
transporters and ligands, caveolins also serve as active modulators of activities of a wide 
variety of signaling molecules, and in particular by inhibiting the endothelial nitric oxide 
synthase (eNOS) (Bucci et al., 2000, Lajoie et al., 2009).
Despite an abundant literature on the role of cav-1 in modulating eNOS and its physiological 
consequences in the periphery (Bernatchez et al., 2005), in comparison little is known about 
the potential roles of caveolins after brain injury. In several models of adult brain injuries, 
the level of expression of cav-1 is increased in the endothelium for several days following 
cold cortical injury (Nag et al., 2007, Nag et al., 2009), brain ischemia(Jasmin et al., 2007) 
and experimental spinal cord injury(Shin et al., 2005, Shin, 2007). Although cav-1 increase 
in some of these brain injury models was associated with BBB or blood-spinal cord barrier 
breakdown (Nag et al., 2007, Nag et al., 2009), the exact role of these changes in cav-1 is 
Badaut et al. Page 2
Neuroscience. Author manuscript; available in PMC 2016 January 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
still unclear. Experiments using cav-1 knockout (cav-1−/−) mice suggest beneficial roles for 
cav-1 in rodent models of brain disorders (Jasmin et al., 2007, Gu et al., 2011). In fact, 
cav-1−/− mice presented higher vascular permeability (Schubert et al., 2002, Siddiqui et al., 
2011) and intriguingly have a worse outcome than the wild-type (WT) with increased 
cerebral volume of infarction after stroke (Jasmin et al., 2007). Interestingly, claudin-5, a 
protein involved in tight junction (TJ) formation and p-glycoprotein (P-gp), an ATP-binding 
protein, were shown to bind to cav-1 and be stabilized by it (McCaffrey et al., 2007, 
Stamatovic et al., 2009, McCaffrey et al., 2012). It is therefore plausible that increase in 
cav-1 expression may be contributing to the recovery of TJ and BBB functions after injury.
Apart from cav-1, cav-2 was also shown to be abundant in endothelial cells, and cav-2−/− 
mice showed a decreased lesion volume compared to WT after stroke (Jasmin et al., 2007). 
This suggests that cav-2 may have a detrimental role in brain injury, in contrast with cav-1. 
Lastly, cav-3 expression was also shown to change in spinal cord astrocytes in a model of 
experimental autoimmune encephalomyelitis (Shin et al., 2005) and could also have a role to 
play in some cerebral pathologies.
The changes in expression of these caveolins are potentially contributing to the 
neurovascular dysfunctions observed after jTBI (Fukuda et al., 2012, Pop et al., 2013). The 
expression and distribution profiles of cav-1, -2, and -3 within the neurovascular unit after 
jTBI in conjunction with BBB dysfunction have not been investigated in association with 
the changes of eNOS activation. The goal of the present study was, therefore, to follow 
changes in the level of expression of cav-1, -2, and -3, in parallel with the changes in BBB 
functions and eNOS signaling during the first week after jTBI.
2. Material and Methods
2.1. Animals
Manuscript was written in accordance with the ARRIVE guidelines. All animal related 
protocols and procedures in this study were approved by the Institutional Animal Care and 
Use Committee of Loma Linda University. Male Sprague-Dawley rat pups at postnatal day 
10 (P10, Harlan, Indianapolis, IN) were housed on a 12-hour light-dark cycle at constant 
temperature and humidity for one-week prior to surgery to allow sufficient time for 
acclimatization. Following induction of experimental brain injury or sham procedure at P17 
(30± 4 g, n=66 rats), the pups were returned to their cages with their dams and subsequently 
weaned at 7d. They were housed two rats per cage, and fed with standard lab chow and 
water ad libitum. Identical sham or controlled cortical impact (CCI) surgical parameters 
were used for the experimental brain injury.
2.2. Juvenile Traumatic Brain Injury Model
Controlled cortical impact (CCI) was induced in P17 old rat pups as previously described 
(Ajao et al., 2012, Fukuda et al., 2012). Briefly, rat pups were anesthetized with isoflurane 
(Webster Veterinary Supply, Inc., Sterling, MA) and placed into a stereotaxic frame (David 
Kopf Instruments, USA). A 5 mm diameter craniotomy was drilled over the right parietal 
cortex at 3 mm anterior-posterior and 4 mm medial-lateral to bregma. CCI was induced in 
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the jTBI group using a 2.7mm diameter rounded-tip metal impactor fixed to an 
electromechanical actuator (Leica Microsystems Company, Richmond, IL) and centered 
over the exposed dura at a 20° angle to the cortical surface. The impact was delivered at a 
velocity of 6 m/s, with impact duration of 200 ms, and to a depth of 1.5 mm from the 
cortical surface. Bleeding and convexity of the injured cortex were recorded and showed no 
significant difference within the jTBI animals. The surgical site was sutured closed. 
Appropriate pain management was provided through subcutaneous administration of 
Buprenorphine (0.01 mg/kg; dilution: 0.01 mg/ml) immediately following end of suturing. 
The body temperature was maintained at 37°C throughout the surgical procedure. Sham 
animals underwent identical procedures with the exception of cortical impact. All rats 
recovered from anesthesia within 25 minutes post-injury. No seizures resulting from 
experimental procedure was observed within the 2 to 3-hour observation period immediately 
following injury when the animals were returned to their cages.
2.3. Astrocyte cultures
Primary cortical astrocyte-enriched cultures were prepared from mice at postnatal day 1 as 
previously described (Pellerin and Magistretti, 1994). Following isolation of cortices and 
removal of the meninges, dissociated cells were suspended in DMEM supplemented with 
10% FCS and Antibiotic-Antimycotic. Cells were seeded on 24-well plates for growing 
period of 21 (±2) d at 37°C and 5% CO2. Medium was exchanged every 3–4 d. Cells were 
fixed with PFA 4% in PBS for 15min and then rinsed with PBS 3 times before to perform 
the immunohistochemistry.
2.4. Western Blotting
A set of rats was prepared with 5 to 7 animals per group at 1d, 3d and 7d brains were freshly 
dissected and the cortical tissue adjacent to the site of the impact was collected. Tissues 
were prepared in RIPA buffer with a cocktail of protease inhibitors (Roche, Basel, 
Switzerland) and sonicated for 30s. After BCA protein assay, 10 µg of protein was then 
subjected to SDS polyacrylamide gel electrophoresis on a 4–12% gel (Nupage, Invitrogen, 
Carlsbad, CA). Proteins were then transferred to a polyvinylidene fluoride membrane as 
indicated by the supplier (PerkinElmer, Germany). The blot was incubated with a rabbit 
polyclonal against cav-1 (BD Biosciences, 1:2000), pi-eNOS (cell signalling, 1:1000), and a 
monoclonal antibody against Tubulin (Sigma, USA, 1:10,000); a monoclonal antibody 
against cav-2 or cav-3 (BD Biosciences, 1:2000), claudin-5 (1:200, Life Technologies: 
Invitrogen, Grand Island, NY, USA), P-gP (1:100, EMD Chemicals, Merck KGaA, 
Darmstadt, Germany) and a polyclonal antibody against actin (Sigma, USA, 1:25,000) in 
Odyssey blocking buffer (LI-COR, Bioscience, Germany) overnight at 4°C. After washing, 
the blot was incubated with two fluorescence-coupled secondary antibodies (1:10,000, anti-
rabbit Alexa-Fluor-680nm, Molecular Probes, Oregon and anti-mouse IR-Dye-800-nm, 
Roche, Germany) for 2 hours at room temperature. After washing, the degree of 
fluorescence was measured using an infra-red scanner (Odyssey, LI-COR, Germany).
2.6. Tissue Processing and Immunohistochemistry
A second set of rats were transcardially perfused with 4% PFA prepared in PBS at 1d, 3d, 
and 7d with n=5 rats per group (jTBI and sham) for each time points. The brains were 
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removed and immersed in 30% sucrose at 4°C for 48 hours and then frozen on dry ice and 
stored at −20°C pending tissue cutting. Coronal cryostat sections (Leica CM1850, Leica 
Microsystems GmbH, Wetzlar, Germany) were prepared.
2.3.1. IgG extravasation staining for BBB assessment—To evaluate the BBB 
disruption, IgG extravasation staining was performed as previously described (Badaut et al., 
2011). Briefly, the sections were incubated with biotin conjugated affinity purified goat anti-
rat IgG coupled with Infrared-Dye-800-nm (1:500 dilution; Rockland, Gilbertsville, PA) in 
PBS containing 0.1% Triton X-100 and 1% bovine serum albumin (BSA) for 2 hours at 
room temperature. After washing, sections were dried and scanned on an infra-red scanner 
(Odyssey-system, LiCor, Germany) to quantify the area of the IgG extravasation for three 
adjacent slices covering the lesion with the LI-COR Odyssey system.
2.3.2. Double immunohistochemistry analysis—All antibody incubations were 
carried out in PBS (Fisher Scientific, Pittsburgh, PA) containing 0.25% Triton X-100 and 
0.25% BSA (both from Sigma-Aldrich Co., St. Louis, MO). After washes in PBS, sections 
were blocked for 1.5 hours in PBS with 1% BSA, and then incubated overnight at 4°C with 
one of the following: mouse anti-cav-1 or -2 or -3 (each diluted 1:200; BD Biosciences, San 
Jose, CA), rabbit anti-cav-1 (1:200; Abcam Inc., Cambridge, MA), mouse anti-claudin-5 
(1:100; Invitrogen, Camarillo, CA), mouse anti-P-gP (1:100, EMD Chemicals, Merck 
KGaA, Darmstadt, Germany), mouse anti-NeuN (1:500; Abcam Inc., Cambridge, MA), 
rabbit polyclonal antibodies for IBA-1 (1:300; Wako), and chicken anti-glial fibrillary acidic 
protein (GFAP, 1:1000; Millipore, Billerica, MA). After 3×10min PBS rinses, sections were 
incubated for 2 hours at room temperature with a mixture of goat anti-mouse secondary 
antibody coupled with Alexa-Fluor-488 and goat anti-rabbit secondary antibody coupled 
with Alexa-Fluor-568 (both at 1:1000; Invitrogen, Camarillo, CA) and subsequently rinsed 
again in PBS for 3×10 minutes. Sections stained with the antibodies mentioned were all 
mounted on glass slides and coverslipped with anti-fading medium vectashield containing 
DAPI (Vector, Vector Laboratories, Burlingame, CA).
Negative control staining where the primary antibody was omitted showed no detectable 
labelling.
The area of cav-1 and cav-2 immunolabeling was quantified at 1, 3, 7, and 60d from a series 
of images collected at 20× objective (422 µm × 338 µm) in perilesional parietal cortex and 
ipsilateral temporal cortex using an epifluorescent microscope with the same parameters for 
all animals (Olympus, BX41, Center Valley, PA). Images were acquired from five serial 
coronal slices separated by 500 µm (24 images per animal). The area of cav-1 and cav-2 
staining was measured for each individual image with MorphoPro software (Explora-Nova, 
La Rochelle, France) according to the following procedure: 1) Top Hat morphologic filter to 
outline vascular staining from the background, 2) user-defined threshold value applied to 
each image. Final values were represented as a percentage of the sham group.
2.7. Statistical analyses
All data are presented as mean ± SEM, statistical analyses were done using SPSS, and 
graphs obtained using SigmaPlot. The IgG extravasation, cav-1, cav-2 immunolabeling, and 
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western blot data were analyzed using student t-tests for normally distributed data with 
comparison between the sham and jTBI groups for each individual time points.
3. RESULTS
3.1. Blood-Brain Barrier disruption in early time-points after jTBI
Changes in BBB integrity were assessed at various time-points following jTBI. In order to 
evaluate BBB disruption from 1d to 7d on the same group of rats, we used the IgG 
extravasation staining (Fig. 1A–C). Increased staining of extravasated IgG was observed in 
the perilesional area and contralateral cortex of jTBI animals (Fig. 1B, C) at 1d and 3d 
compared to the sham group. The IgG staining decreased back to normal (i.e. sham) level at 
7d (Fig. 1B, C). Quantification of extravasated IgG showed a significant increase in the 
perilesional cortex of jTBI rats at 1d and 3d compared to sham (respectively 0.023 ± 0.033 
mm2 vs 0.002 ± 0.001 A.U and 0.035 ± 0.042 A.U vs 0.002 ± 0.001 A.U, p<0.05, Fig. 1C). 
This suggests that BBB disruption is maximum at 1d and 3d post-injury, which is in 
agreement with our previous observations that showed vasogenic edema formation between 
1d and 3d, followed by normalization after 7d (Fukuda et al., 2012).
To further characterize the changes in BBB properties, we carried out western blot and 
immunohistochemical analyses for two key proteins for BBB function, a protein of the tight 
junctions, claudin 5 and for an ATP binding transporter, P-gp in accordance with our 
previous work (Pop et al., 2013). Interestingly, western blot analysis of the level of 
expression of claudin-5 exhibited a bi-phasic variation characterized by a 21% decrease of 
claudin-5 expression in the jTBI group compared to the sham at 3d (p<0.05, Fig. 1D). Such 
a decrease in claudin-5 expression corresponds to the peak of BBB disruption (Fig. 1B, C). 
On the other hand, the normalization of IgG extravasation is associated with a significant 
increase of the claudin-5 expression of 39% in jTBI group compared to the sham by 7d (Fig. 
1D). Correspondingly, Claudin-5 IR associated with blood vessels exhibited a decrease at 3d 
in the ipsilateral cortex in the jTBI group compared to the sham group (Fig. 1E2,F2). At 7d, 
claudin-5-IR found on blood vessels was increased compared to the sham level (Fig. 
1E3,F3), suggesting a compensatory mechanism as we previously described at 60 days post 
jTBI (Pop et al., 2013). P-gp expression analysis by western blot, revealed a 37% increase 
(p<0.05) in jTBI group compared to the sham at 7d (Fig. 1G). The immunohistochemistry 
staining illustrated that the significant increase of P-gP staining at 7d (Fig 1I) compared to 
the sham (Fig 1I) occurs in the blood vessels outlined with tomato-lectin staining (t-lectin).
3.2.Changes in expression of caveolin-1, -2, and -3 within the neurovascular unit after jTBI
3.2.1 Immunocytochemical localization of the three caveolins in the cortex 
after jTBI—In order to determine the cellular localization of cav-1, various cav-1 
antibodies were used in double immunostaining with other cell markers to identify the cell 
distribution of cav-1 after jTBI in the tissue adjacent to the lesion and remotely. As 
previously described, anti-cav-1 staining showed that cav-1 is predominantly expressed in 
brain endothelial cells (Fig. 2A, B) of all cerebral blood vessels, independent of the diameter 
(from the pial vessels to intracerebral arterioles and capillaries) in normal brain (not shown) 
and at distance from the site of the injury. In parallel, cav-2-IR was observed in brain 
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endothelial cells in brain blood vessels of all sizes including pial blood vessels in both sham 
and jTBI groups (Fig. 2C). Double immunolabeling for cav-1 and cav-2 showed the co-
localization of the two proteins in the endothelium of cerebral blood vessels, suggesting that 
cav-1 and cav-2 could bind together (Fig 2D1–3). Double immunolabeling for GFAP and 
cav-1 showed co-localization, suggesting the presence of cav-1 in reactive astrocytes at the 
border of the lesion at 1d and 3d following jTBI (Fig. 2E1–3). Anti-cav-1 staining also co-
localized with mouse anti-NeuN staining (Fig. 3A), suggesting an increased 
immunoreactivity of cav-1 in neurons located around the lesion site at 3d post-injury. 
However, cav-1 staining did not co-localize with IBA-1 staining, a marker of microglial 
cells (Fig. 3B). Cav-3 immunostaining was observed in astrocytes located in the glia 
limitans, cortex, hippocampus, white matter tract and hypothalamus in both groups (data not 
shown). Double immunolabeling of GFAP and cav-3 confirmed the presence of cav-3 in 
astrocytes (Fig. 2F). A positive immunostaining for cav-1 was observed in primary astrocyte 
cultures, confirming its presence in reactive astrocytes (Fig. 2G). Similarly, positive cav-3 
IR was observed in the primary astrocyte cultures (Fig. 2H).
3.2.2 Time-dependent changes in caveolin-1 expression following jTBI—The 
relative changes of cav-1-IR in the ipsilateral cortical tissue, including the cavity at 1d, 3d 
and 7d following jTBI were quantified by western blot. A specific band was observed at 22 
kDa, and the changes of cav-1 expression showed a bi-phasic profile (Fig. 4A) during the 
first week after the injury. The level of expression of cav-1 was significantly increased in 
jTBI compared to sham at 1d and 7d (Fig. 4A, B; p<0.05). At 3d, the level of expression of 
cav-1 was slightly decreased compared to the sham. The immunohistochemical labeling for 
cav-1 showed a similar pattern in the endothelium, with an increase in the staining of brain 
cortical blood vessels from 1d and 7d (Fig. 4D1, D2) in the perilesional area compared to 
the sham groups (Fig. 4C1, C2). In fact, the immunofluorescence quantification showed that 
cav-1-IR in cerebral blood vessels in the ispilateral cortex is significantly increased by 36% 
at 1d and 92% at 7d compared to the sham groups (p<0.05).
3.2.3 Time-dependent changes in caveolin-2 expression following jTBI—The 
relative changes of cav-2-IR in the ipsilateral cortical tissue at 1d, 3d and 7d following jTBI 
were quantified by western blot. The western blot showed a band around 24 kDa in both 
sham and jTBI (Fig. 5A). Interestingly, the level of expression of cav-2 showed a similar 
pattern of changes than cav-1, with an increase of its expression at 1d and a significantly 
higher at 7d in jTBI animals compared to the sham group. However, there is no difference at 
3d, with the same level of expression between sham and jTBI (Fig. 5A). The analysis of the 
level of cav-2 immunofluorescence was performed on the same regions of interest that was 
used for cav-1. As observed with the western blot analysis, cav-2 immunofluorescence is 
significantly increased by 95 % in cortical blood vessels in jTBI group compared to sham at 
7d post-injury (Fig. 5B, C).
3.2.4 Time-dependent changes in caveolin-3 expression following jTBI—The 
relative changes of cav-3-IR in the ipsilateral cortical tissue at 1d, 3d and 7d following jTBI 
were quantified by western blot. Western blot of cav-3 showed a band around 20kDa (Fig 
6A). A significant decreased of cav-3 expression at 3d and 7d in jTBI groups was observed 
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compared to the sham groups (Fig. 6A, B). Immunohistochemical analysis of cav-3 showed 
changes in the pattern of the staining. First, the presence of cav-3 in glia limitans is not 
observed in jTBI animals at 3 and 7d post-injury (Fig. 6D2, 6D3) compared to sham animals 
(Fig. 6C2, 6C3). Surface area of cav-3 staining is also more extended in the astrocytes in the 
vicinity of the cortical lesion (Fig. 6D2, 6D3) compared to the sham group (Fig. 6C2, 6C3), 
an effect that is likely due to the changes of the properties of the astrocytes after jTBI. 
Overall the intensity of cav-3 immunofluorescence at 3 and 7d post-jTBI (Fig. 6D2, 6D3) 
seems to be decreased compared to the sham group (Fig. 6C2, 6C3).
3.3. Changes in eNOS signaling in early time-points after jTBI
As indicated in the introduction, caveolin is known to bind to eNOS and to regulate its 
activation. We addressed the question of eNOS activation under our conditions by 
measuring the level of phospho-eNOS (pi-eNOS) by western blot. Total eNOS expression 
was not different between the groups, while pieNOS appearing as an expected band at 140 
kDa, exhibited changes between the groups. The level of expression of pi-eNOS in the jTBI 
group is augmented by 49% compared to sham at 1d (Fig. 7A). In a second phase, the 
expression of pi-eNOS is significantly decreased in the jTBI group compared to sham by 
22% at 3d (Fig. 7A). There was no difference at 7d after brain injury. Immunohistochemical 
labelings showed that the expression of pi-eNOS is present in the endothelium (Fig. 7B) of 
blood vessels outlined by tomato-lectin staining (Fig. 7C). Surprisingly, a large part of the 
expression of pi-eNOS was associated with the astrocytes suggesting that the global changes 
of pi-eNOS expression observed in the perilesional cortex might also be due to astrocytic 
expression. The presence of pi-eNOS in astrocytes was confirmed by a positive 
immunolabeling in primary astrocyte cultures (Fig 7D) co-localizing both in vitro and in 
vivo after jTBI with cav-3 in astrocytes (Fig. 7D,E) and cav-1 (data not shown). Cav-1 and 
pi-eNOS also co-localized in the endothelium of blood vessels in addition to astrocytes (Fig. 
7F), suggesting potential interactions between the molecular pathways.
4. DISCUSSION
Traumatic brain injury in the juvenile population is known to be associated with greater 
risks of cerebral hemodynamic dysfunction, BBB disruption, and diffuse cerebral edema, 
compared to adults (Armstead, 1999, Campbell et al., 2007, Giza et al., 2007). BBB 
disruption in clinical patients is known to be a major cause of mortality and long-term 
neurological deficits in victims with moderate to severe TBI (Shlosberg et al., 2010). There 
is also more evidence indicating that in mild TBI such as in blast injury, the BBB is 
impaired early on after the injury (Readnower et al., 2010). Hence, there is a need to study 
BBB changes in jTBI after injury as well as the molecular processes involved in BBB repair. 
The jTBI model showed a significant increase in IgG extravasation with a peak at 3d, 
paralleled with the loss of claudin-5 staining in the cortex, and these findings indicate a 
physical BBB disruption during the development of secondary injuries. It is interesting to 
note that BBB disruption parallels the peak of edema formation previously observed on the 
T2-weighted MRI in a similar jTBI model (Fukuda et al., 2012). At 7d, the extravasation of 
IgG returned to sham levels when claudin-5 expression is increased, suggesting a recovery 
of BBB tight junctions. Similarly, BBB recovery parallels the increase of P-gp and the 
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decrease in vasogenic edema previously observed as a return to the normal T2 values on T2-
weighted MRI scans at 7d in a similar injury model (Fukuda et al., 2012). It is interesting to 
outline that the increase of claudin-5 expression observed at 7d is still present 2 months 
post-jTBI (Pop et al., 2013), which is part of the long-term phenotypic changes at the 
endothelium.
Increase of cav-1 and cav-2 expression in endothelial cells predicts BBB recovery
Endothelial cav-1 and cav-2 proteins could be good molecular candidates to study with 
regard to changes in BBB properties because of their possible involvement in the regulation 
of several intracellular signaling processes (Bucci et al., 2000, Gu et al., 2011). In fact, cav-1 
was shown to be involved in the regulation of eNOS activity (Bucci et al., 2000, Bernatchez 
et al., 2005), as well as in the stabilization of tight junction proteins such as claudin-5 within 
the lipid raft domain and of P-gp (Jodoin et al., 2003, McCaffrey et al., 2007, McCaffrey et 
al., 2012). Enhancement of cav-1 expression was proposed to be beneficial in cerebral 
ischemia model by limiting the increase of activation of eNOS, and NO production with for 
consequences a limited activation of matrix metalloproteinases (MMPs) and reduced 
degradation of the perivascular extracellular matrix (Gu et al., 2011).
After jTBI, cav-1 but also cav-2 expression is slightly increased at 1d, before to go back to 
the value observed in sham groups. However, the increase of both caveolins seems to have 
no effect to limit the activation of eNOS, represented by a significant increase of pi-eNOS. 
This result strongly suggests that in jTBI an increase of NO production occurs, unabated by 
enhanced caveolin expression, with a toxic effect on the BBB properties. At the peak of the 
BBB disruption (measured with IgG extravasation), claudin-5 was significantly decreased 
when cav-1 and cav-2 protein expression in jTBI rats showed values similar to shams. At 
this time point pi-eNOS is decreased, further showing that eNOS activation seems 
independent of caveolin expression levels.
The profile of cav-1 and 2 expression in the endothelial cells after jTBI shares some 
similarities with previous findings in other adult rodent models of CNS insults. In fact, an 
early increase of cav-1 in the endothelial cells preceded the decrease of claudin-5 and 
occludin (Nag et al., 2007, Nag et al., 2009). From this study, the authors concluded that the 
increase of cav-1 expression could potentially contribute to BBB disruption by inducing 
transcytosis of proteins across the cerebral endothelium (Nag et al., 2007, Nag et al., 2009). 
In contrast, cav-1 could exhibit some effects rather promoting BBB integrity. Thus, tight 
junction proteins such as claudin-5 and occludin have been shown to bind to and be 
stabilized by cav-1 within the caveolae (McCaffrey et al., 2007). After hypoxia-
reoxygenation, levels of claudin-5 and occludin found within the caveolae were all together 
reduced (McCaffrey et al., 2007, McCaffrey et al., 2009). From this work, cav-1 was rather 
proposed to play a beneficial role in the maintenance of these tight junction protein subunits 
(McCaffrey et al., 2007, McCaffrey et al., 2009, Stamatovic et al., 2009). Moreover, 
cav-1−/− mice presented higher endothelial permeability in the systemic vasculature 
compared to WT (Razani et al., 2001, Schubert et al., 2002). Therefore, a decrease in cav-1 
expression may suggest a disruption in the BBB integrity (as observed from 1d to 3d after 
jTBI following the initial increase), whereas an increase of cav-1, as observed at 7d, may be 
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beneficial toward the recovery of the BBB integrity after jTBI. In support of this hypothesis, 
cav-1−/− mice showed a larger lesion volume compared to WT in a transient middle cerebral 
artery occlusion model (Jasmin et al., 2007). The beneficial role of cav-1 could involve 
different mechanisms: 1) cav-1 seems essential to promote angiogenesis as its absence is 
detrimental due to a decrease in angiogenesis in cav-1−/− mice compared to WT (Jasmin et 
al., 2007); 2) since cav-1 has a caveolin scaffolding domain that binds to eNOS and inhibits 
its activity (Bucci et al., 2000), it could prevent the toxic effects of NO (Gu et al., 2011). 
Indeed, a decrease of NO formation following an increase of cav-1 expression in a stroke 
model has been shown to be associated with decreased activation of MMPs (Gu et al., 2011) 
and consequently to a protection of the BBB. Therefore, the experiments with cav1−/− 
suggest that an increase of cav-1 expression in the endothelium at 7d following jTBI may be 
an endogenous mechanism aimed at facilitating BBB recovery during the first week. 
However, considering the time course of the changes observed with the different proteins, 
the parallel changes of cav-1 and cav-2 expression and the improvement of the BBB 
strongly suggest that an increased expression of these proteins may stabilize other BBB 
proteins like claudin-5 and P-gP, rather than to play directly on the NO pathway as it was 
proposed in stroke (Gu et al., 2011). So far, the exact role of cav-1 in brain injury and 
especially in jTBI remains unknown, and detrimental effects of acute cav-1 increase cannot 
be ruled out. In fact, an increase in cav-1 and cav-2 staining could be associated with an 
increase in the number of caveolae, which in turn is responsible for increased transcytosis 
(Jodoin et al., 2003, Regina et al., 2004) and the entrance of albumin, which may contribute 
to the dysfunction of the brain tissue homeostasis (Komarova and Malik, 2010). Indeed, 
such an effect could be associated with the early increase in cav-1 after 1 day and participate 
to the early BBB disruption as previously proposed (Nag et al., 2007, Nag et al., 2009).
Cav-1 and cav-3 expression in astrocytes: negative role in astrogliosis?
In the juvenile rat brain, the main cav-1 and cav-2 expression is associated with the 
endothelial cell layer of cerebral blood vessels of all sizes (from capillaries to pial arteries) 
in accordance with previous studies carried out in adult mammalian brains (Cameron et al., 
1997, Virgintino et al., 2002). However, the expression of the caveolins was not limited to 
the endothelial cells. Cav-1 was also found in some parenchymal cells such as astrocytes and 
neurons in the jTBI group, a finding also reported in previous studies (Ikezu et al., 1998, 
Virgintino et al., 2002, Head et al., 2008). The presence of cav-1 in astrocytes, which co-
localizes with GFAP staining in vivo as reported before (Ikezu et al., 1998), was confirmed 
in primary astrocyte cultures like observed in previous work (Wiencken and Casagrande, 
1999).
In addition to cav-1, reactive astrocytes after jTBI exhibited the presence of cav-3 staining. 
Indeed, cav-3 co-localized with GFAP staining in vivo, which is consistent with previous 
studies in adult models (Ikezu et al., 1998, Shin et al., 2005) and confirmed in the primary 
astrocyte cultures. Although cav-3 has been reported in smooth muscles (Ikezu et al., 1998), 
we did not observe any cav-3 staining in intraparenchymal cerebral blood vessels. The 
expression and localization of cav-3 in jTBI brains appear to coincide with astrogliosis, 
which is similar to findings in experimental autoimmune encephalomyelitis (Shin et al., 
2005). However, the level of expression of cav-3 is significantly decreased at 3 and 7 days 
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post-injury. Associated with this decrease of the protein level, the pattern of cav-3 staining 
changed with a weaker signal in astrocyte processes in jTBI compared to shams. A 
possibility is that the decrease of cav-3 could be compensated by the increase of cav-1 
expression in reactive astrocytes, which was mostly detected with a rabbit polyclonal anti-
cav-1 as previously described (Virgintino et al., 2002, Shin et al., 2005). The exact roles of 
these proteins in astrocytes in vivo are still unknown. Caveolins can be associated with 
eNOS, which was previously shown to be present in astrocytes of the rat brain (Colasanti et 
al., 1998, Wiencken and Casagrande, 1999). In our experiments, we observed the presence 
of pi-eNOS in astrocytes both in vitro and in vivo. Moreover, both cav-3 and cav-1 present 
in astrocytes co-localized with pi-eNOS after jTBI. In astrocytic culture, cav-1 was observed 
to function as an endogenous inhibitor of eNOS activation (Colasanti et al., 1998). However, 
the changes in pi-eNOS expression are independent of cav-1 and cav-3 expression, thus 
questioning a role of caveolins in a putative inhibition of eNOS activation and excess release 
of NO following jTBI. Interestingly, the changes of the level of expression of cav-1 in 
astrocyte cultures were associated with opposite changes in expression of the glutamate 
transporter GLT1 (Zschocke et al., 2005, Gonzalez et al., 2007). The application of 
transforming growth factor-alpha (TGF-α) induced a decrease of cav-1 and an increase of 
GLT1 (Zschocke et al., 2005, Gonzalez et al., 2007). Increase of cav-1 expression in the 
astrocyte may, therefore, participate to the mechanism producing a downregulation of GLT1 
in the astroglia. Such a reduced GLT1 expression could have important consequences on 
glutamate uptake and excitotoxicity after jTBI. Additional experiments will be needed to 
determine the functional roles of these 2 caveolins in astrocytes.
Summary
Cav-1 and cav-2 expression profile after jTBI parallels the resolution of the BBB disruption 
using claudin-5 and P-gp expression as markers. In contrast with adult brain injury, the 
changes in cav-1 and cav-2 expression are not directly related to the inhibition of eNOS 
activation revealed indirectly with the level of expression of pi-eNOS. These observations 
suggest that the molecular mechanisms involved in BBB dysfunctions could differ 
depending of the cause of the insult as well as the age at which it occurs. Moreover, each 
cell constituting the NVU (i.e. endothelial cell, neuron, astrocyte) has to be considered, 
especially with the finding of the presence of cav-1 and cav-3 in astrocytes. This study 
shows for the first time changes in the expression of these molecules in a model of jTBI and 
the complexity of the role of the caveolins. Further studies will be needed to characterize the 
role of each caveolin in each cell type after jTBI.
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Highlights
1. Phenotypic changes of the blood-brain barrier after Juvenile TBI
2. Endothelial and astrocyte expression of caveolins after juvenile TBI
3. Role of caveolins in cerebrovascular dysfunctions after juvenile TBI
4. Relationship between changes of expression of caveolins and eNOS and 
proteins of the BBB
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Figure 1. BBB disruption after jTBI
(A, B) IgG extravasation staining in sham (A) and jTBI (B) at 1, 3, and 7d post injury. Area 
of IgG staining (black) is enlarged at 1 and 3d in jTBI animals (B) compared to sham (A), 
but normalizes by 7d (A, B).
(C) Quantification of IgG immunoreactivity shows a significant increase at 1 and 3d, but not 
at 7d (E; p<0.05).
(D) Western blot of claudin-5 showed a band around 22kDa and is significantly decreased in 
jTBI compared to sham at 3 and increased 7d. The quantification of the intensity of the band 
for claudin-5 was normalized to the tubulin (55kDa).
(E, F) A tight junction protein Claudin-5 staining in the sham (E) and jTBI (F) at 1d (E1, 
F1), 3d (E2, F2) and 7d (E3, F3). Accordingly to western blot (D), the staining of claudin-5 
is lower in jTBI (E2) than sham group (F2) at 1d and 3d. Intensity of claudin-5 staining in 
jTBI group is increased at 7d after the injury (E3, F3).
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(G) Western blot of P-gp showed a band around 122kDa and is significantly increased in 
jTBI compared to sham at 7d. The quantification of the intensity of the band for P-gp was 
normalized to the tubulin (55kDa).
(H, I) Tomato-lectin (t-lectin, green, H1, I1) was co-stained with P-gp immunolabeling (red, 
H2, I2) in the sham (H) and and jTBI (I) at 7d. Accordingly to western blot (G), the staining 
of P-gp is increased in intensity (red) in blood vessels (outlined by t-lectin, green) in jTBI 
animals compared to shams.
E, F, H, I bar = 100µm
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Figure 2. Caveolin distribution in vascular endothelium and astrocytes
(A) Mouse anti-cav1 (green) exhibit a staining in the cerebral blood vessels (asterisk), from 
the large blood vessels to capillary bed (arrows). Co-staining cav-1 (green) and anti-GLUT1, 
marker for the endothelial cells, shows a co-localization in yellow (arrow heads) in large 
blood vessels as well as in capillaries.
(B) The co-staining cav-1 (green) and anti-GFAP (red) did not show overlap in parietal 
cortex at distance to the injury site, astrocytic cav-1 staining may be contained within 
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reactive astrogliosis around the injury (arrowhead = astrocyte endfeet, arrow = cav1 in 
endothelium).
(C) Caveolin-2 (cav-2, green) and GFAP (red) did not exhibit co-localization, only 
endothelial staining was observed.
(D) Double immunolabeling cav-2 (C1, green C3) and cav-1 (C2, red C3) showed co-
localization between both staining in the endothelial cells (arrows).
(E) In the perilesional areas, rabbit anti-cav-1 staining (red, C2, C3) was co-localized with 
GFAP labeling (green, C1, C3) (arrowheads), which is an astrocytic marker and increased in 
reactive astrogliosis.
(F) Cav-3 staining (red) and GFAP labeling (green) showed co-localization (yellow, 
arrowheads), showing the presence of cav-3 in astrocyte process and cell bodies.
(G) Cav-1 labeling (red) and nuclear staining with DAPI (blue) in primary astrocyte culture 
shows presence of cav-1 in the astrocytes.
(H) Cav-3 labeling (green) and nuclear staining DAPI (blue) in primary astrocyte culture 
show the presence of cav-3 protein in the astrocyte.
A = 50µm B, C, D, E, bar = 100µm; F, G, bar=10µm
Badaut et al. Page 19
Neuroscience. Author manuscript; available in PMC 2016 January 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Caveolin 1 expression in neurons but not microglial cells after jTBI
(A) NeuN labeling (green, A1, A3) and Cav-1 staining (red, A2, A3) co-localized (yellow, 
arrowheads), suggesting the presence of cav-1 in neurons in the periphery of the lesion. 
Cav-1 staining (red, A2, A3) is also observed in intracortical microvessels (arrows).
(B) Cav-1 labeling (green, B1, B3, arrows) and IBA1 staining (red, B2, B3, arrowhead), a 
marker of microglial cells, did not show co-localization.
A, bar = 500µm; B, bar = 100µm
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Figure 4. Caveolin 1 Expression after jTBI
(A) Western blot for cav-1 showed monomer at 22 kDa and tubulin at 55kDa in sham and 
jTBI ipsilateral cortex. Cav-1 is increased at 1d and 7d in jTBI animal compared to shams. 
In contrast at 3d, the intensity of the band for cav-1 is lower in jTBI group than sham
(C) Quantification of cav-1 from western blots showed significant increases in jTBI animals 
compared to sham at 1d and 7d (*, p<0.05). The increase is significantly higher at 7d than at 
3d in jTBI animals (#, p<0.05).
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(C, D) Caveolin-1 (cav-1) staining in the sham (C) and jTBI (D) at 1d (C1, D1) and 7d (C2, 
B2) after the injury. Less endothelial cav-1 staining was observed throughout the time-points 
studied in sham (A) compared to jTBI (B).
C, D, bar = 100µm
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Figure 5. Caveolin 2 Expression expression after jTBI
(A) Western blot of cav-2 showed a band around 20kDa with a significant increase in 
intensity between sham and jTBI group at 7d post-injury (*p<0.05). In jTBI group, cav-2 is 
significantly increase between 3 and 7d (#, p<0.05)
(B, C) Cav-2 staining in the sham (C) and jTBI (D) at 7d exhibits higher intensity of 
staining in cortical blood vessels of the jTBI group than in sham
B, C, bar = 100µm
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Figure 6. Caveolin-3 Expression and Distribution after jTBI
(A) Western blot of cav-3 (red) showed a band around 20kDa and is significantly decreased 
in jTBI compared to sham at 3 and 7d.
(B) The quantification of the intensity of the band for cav-3 was normalized to the tubulin 
(55kDa).
(C, D) Cav-3 staining in the sham (C) and jTBI (D) at 1d (C1, D1), 3d (C2, D2) and 7d (C3, 
D3). In accordance with the western blot, no major changes were observed in cav-3 staining 
at 1d (C1, D1). However, the pattern of cav-3 staining differs between the jTBI and sham 
animals at 3d (C2, D2) and 7d (C3, D3). In the glia limitans, cav-3 staining is decreased in 
jTBI animals (D2, D3) compared to sham (C2, C3). The intensity of cav-3 staining is 
decreased in jTBI animals (D2, D3) compared to sham (D2, D3) despite an increase of the 
extend of the surface staining for cav-3 in jTBI group at both time points.
C, D, bar = 100µm
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Figure 7. pi-eNOS expression and distribution after jTBI
(A) Western blot of pi-eNOS showed a band around 140kDa and is significantly increased 
in jTBI compared to sham at 1d (*, p< 0.05) and decreased at 3d (*, p<0.05). The 
quantification of the intensity of the band for claudin-5 was normalized to the tubulin 
(55kDa).
(B, C) The anti pi-eNOS staining (B, arrows) is present in the blood vessels revealed by 
tomato-lectin staining (t-lectin, C, arrows), but also in the astrocytes (arrowheads) in 
perilesional cortex of jTBI animals.
(D). Double immunolabeling cav-3 (green, D1) and pi-eNOS immunolabeling (red, D1, D2) 
showed a co-localization in primary astrocyte cultures.
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(E) Double immunolabeling cav-3 (green, E1, E3) and pi-eNOS immunolabeling (red, E1, 
E2) showed a co-localization in astrocyte like cells (arrowheads) in the cortex of jTBI rats.
(F) Double immunolabeling cav-1 (green, F1, F3) and pi-eNOS immunolabeling (red, F1, 
F2) showed a co-localization in endothelial cells (arrows) in the cortex and the pial blood 
vessels in jTBI rats. In the glia limitans, pi-eNOS staining was observed in the astrocytes of 
the glia limitans (arrowheads).
B, C, E, F bar = 50µm; D bar = 25µm
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